TAU-OPATHY MODEL
    4.
    发明公开
    TAU-OPATHY MODEL 无效
    TAU-OPATHY MODELL

    公开(公告)号:EP1373529A1

    公开(公告)日:2004-01-02

    申请号:EP02702181.5

    申请日:2002-02-25

    申请人: NV reMynd

    摘要: The present invention relates to cell models of Alzheimer's disease. Transgenic yeast cells are described as models for the tau-opathy in Alzheimer's disease. These cell models comprise recombinant DNA constructs comprising control sequences and a cDNA sequence encoding a human tau-isoform and another similar construct comprising a protein kinase that is capable, directly or indirectly, of modulating the phosphorylation of the microtubule-associated protein tau. The transgenic cells are useful for high-throughput testing for potential therapeutic agents for Alzheimer's disease and other neurodegenerative disorders.

    TAU-OPATHY MODEL
    8.
    发明授权
    TAU-OPATHY MODEL 无效
    TAU心肌病模型

    公开(公告)号:EP1373529B1

    公开(公告)日:2008-04-23

    申请号:EP02702181.5

    申请日:2002-02-25

    申请人: NV reMynd

    摘要: The present invention relates to cell models of Alzheimer's disease. Transgenic yeast cells are described as models for the tau-opathy in Alzheimer's disease. These cell models comprise recombinant DNA constructs comprising control sequences and a cDNA sequence encoding a human tau-isoform and another similar construct comprising a protein kinase that is capable, directly or indirectly, of modulating the phosphorylation of the microtubule-associated protein tau. The transgenic cells are useful for high-throughput testing for potential therapeutic agents for Alzheimer's disease and other neurodegenerative disorders.